[Liver-bone axis: novel mechanisms and strategies for MAFLD regulation]. [PDF]
Wang YW, Yan XZ, You H, Yang AT.
europepmc +1 more source
[Research progress on the quercetin target role and signaling pathway in anti-liver fibrosis]. [PDF]
Zhao RQ +9 more
europepmc +1 more source
LncRNA OIP5-AS1调节miR-186a-5p促进肝细胞癌凋亡及糖酵解
目的 探讨lncRNA OIP5-AS1在肝细胞癌(HCC)中的表达及其对肿瘤发展的影响,并揭示其潜在的分子机制。方法 采用实时荧光定量PCR(RT-qPCR)分别检测LncRNA OIP5-AS1和miR-186a-5p在肝癌组织、癌旁组织的表达以及肝癌细胞系HepG2、Hep3B、Huh-7和正常肝细胞系LO2中的表达情况。Pearson相关分析评估LncRNA OIP5-AS1与miR-186a-5p表达水平的相关性。双荧光素酶报告实验检测LncRNA OIP5-AS1与miR-186a ...
臧书宁, 杨正波, 吴惧
doaj
[Mechanisms and clinical research progress of mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease]. [PDF]
Wang N, Xu ZL, Liu DH.
europepmc +1 more source
[Cajanonic acid A derivative XJ-60 improves liver fibrosis in mice with non-alcoholic fatty liver disease by inhibiting the SP1/TGF-β/Smad3 signaling axis]. [PDF]
Geng Z +8 more
europepmc +1 more source
[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Rao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
[Research progress on liver transplantation therapy for hepatic metastases in gastroenteropancreatic neuroendocrine tumors]. [PDF]
Yang K, Zhang WQ, Chen CY, Jiang WT.
europepmc +1 more source
[Heterogeneity of tumor-associated macrophages and precision targeting strategies in hepatocellular carcinoma]. [PDF]
Huang K, Zhang GQ.
europepmc +1 more source
EGCG对人肝癌细胞株HepG2裸鼠移植瘤COX-2、VEGF和bFGF表达的调控
探讨表没食子儿茶素没食子酸脂EGCG对人肝癌细胞株HepG2裸鼠移植瘤生长和肿瘤血管生成的抑制作用及EGCG对移植瘤环氧合酶-2(COX-2)?血管内皮生长因子(VEGF)和碱性成纤维生长因子(bFGF)表达的调控?【方法】 将肝癌细胞HepG2种植至裸鼠背部皮下,10 d后开始用不同浓度EGCG治疗,38 d后处死?观测裸鼠移植瘤的体积和质量?并采用间接免疫流式细胞术和Western Blot法检测移植瘤COX-2?VEGF和bFGF的表达,用免疫组化法检测微血管密度(MVD)?【结果 ...
doaj
[A study on the efficacy and safety profile of transjugular intrahepatic portosystemic shunt received elderly patients with liver cirrhosis]. [PDF]
Cai ZH, Yin Q, Zhang F, Zhuge YZ.
europepmc +1 more source

